DHX9 and lung carcinoma: DHX9 full length but not the DHX9 dsRBDs del which missing the HIF1A-As2 binding domain could reverse the inhibited cell growth by DHX9 KO (Supplementary Fig. 7G), suggesting the important roles of dsRBD domain in lung cancer.